Allergan plc Revenue vs. Current Ratio

AGN -- USA Stock  

USD 161.25  2.14  1.34%

The Drivers Module shows relationships between Allergan plc's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Allergan plc over time as well as its relative position and ranking within its peers. Check also Trending Equities

Allergan plc Current Ratio vs. Revenue Fundamental Analysis

Allergan plc is the top company in revenue category among related companies. It is rated below average in current ratio category among related companies . The ratio of Revenue to Current Ratio for Allergan plc is about  15,223,300,971 
Allergan plc is the top company in revenue category among related companies. Market size based on revenue of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 27.28 Billion. Allergan plc totals roughly 15.68 Billion in revenue claiming about 57% of equities under Drug Manufacturers - Specialty & Generic industry.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Allergan plc 
Revenue 
 = 
Money Received 
Discounts and Returns 
=
15.68B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Allergan plc 
Current Ratio 
 = 
Current Asset 
Current Liabilities 
=
1.03X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e. Current Ration of 2 to 1).

Allergan plc Current Ratio Comparison

  Current Ratio 
      Allergan plc Comparables 
Allergan plc is currently under evaluation in current ratio category among related companies.

Allergan plc Fundamental Comparison

Search macroaxis.com